CPI Compliance Program

CIBMTR established the Continuous Process Improvement (CPI) Compliance Program to ensure timely and accurate submission of data to CIBMTR. These data support CIBMTR’s mission to serve as a collaborative resource of data and experts supporting research in cellular therapy to improve patient outcomes. In addition, CPI supports CIBMTR's ability to perform benchmarking and to provide accurate population level data. These data also support quality assurance efforts for the programs providing the products, including cord blood banks and apheresis and collection centers.

For all centers, the following are basic requirements of the CPI Program:

• Data Transmission Agreement (DTA) / Master Healthcare Data and Sample Submission Agreement (MHA) documents (non-US and US centers)
• Current approved CIBMTR protocols and informed consent documents for the Research Database - IRB (US centers)
• Meet target form completion percentages
• Validate reportable HCTs with the Consecutive Transplant Audit (CTA) process

For more information on specific requirements, refer to CIBMTR's Data Management Guide.